bipartisan cannabis research bill awaits bidens ink 153686

Bipartisan Cannabis Research Bill Awaits Biden’s Ink

Bipartisan Cannabis Research Bill Awaits Biden’s Ink
cnwsq150x150 1
<![CDATA[A standalone cannabis bill is heading to the U.S. president’s desk. That’s right: The U.S. Congress passed the bipartisan Medical Marijuana Cannabidiol Research Expansion Act with the Senate’s voice vote Nov. 16 after the House passed the bill via a 325-95 vote in July. The Senate passed H.R. 8454 (Medical Marijuana and Cannabidiol Research Expansion Act) by voice vote.— Senate Periodicals (@SenatePPG) November 16, 2022 US House Passes Cannabis Research BillPending President Biden’s signature, the legislation will be the first piece of standalone federal cannabis reform enacted since the Controlled Substances Act of 1971 notoriously designated a  plant as a Schedule I drug, according to U.S. Rep. Earl Blumenauer, D-Ore., who sponsored the research bill with Andy Harris, R-Md., in the lower chamber. “After working on the issue of cannabis reform for decades, finally the dam is starting to break,” Blumenauer said in a press release Wednesday. “The passage of my Medical Marijuana and Cannabidiol Research Expansion Act in the House and Senate represents a historic breakthrough in addressing the federal government’s failed and misguided prohibition of cannabis.”The legislation aims to encourage and facilitate research on cannabis and its potential health benefits by streamlining the application process for studies and removing U.S. Food and Drug Administration (FDA) barriers for researchers that often slow the process. The bill was also sponsored by Sens. Dianne Feinstein, D-Calif., Chuck Grassley, R-Iowa, and Bill Schatz, D-Hawaii. “There is substantial evidence that marijuana-derived medications can and are providing major health benefits,” Feinstein said in a press release. “Our bill will make it easier to study how these medications can treat various conditions, resulting in more patients being able to easily access safe medications. We know that cannabidiol-derived medications can be effective for conditions like epilepsy. This bill will help refine current medical CBD practices and…

Excerpt only …
Source : Bipartisan Cannabis Research Bill Awaits Biden’s Ink

reposted by Cannabis News World

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.